IN2012DE00868A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00868A
IN2012DE00868A IN868DE2012A IN2012DE00868A IN 2012DE00868 A IN2012DE00868 A IN 2012DE00868A IN 868DE2012 A IN868DE2012 A IN 868DE2012A IN 2012DE00868 A IN2012DE00868 A IN 2012DE00868A
Authority
IN
India
Prior art keywords
drug
coating composition
time
solid preparation
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Miyuki Fukasawa
Yuichi Nishiyama
Takafumi Hoshino
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45888055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DE00868(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2012DE00868A publication Critical patent/IN2012DE00868A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN868DE2012 2011-03-30 2012-03-23 IN2012DE00868A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011075344 2011-03-30

Publications (1)

Publication Number Publication Date
IN2012DE00868A true IN2012DE00868A (enExample) 2015-09-04

Family

ID=45888055

Family Applications (1)

Application Number Title Priority Date Filing Date
IN868DE2012 IN2012DE00868A (enExample) 2011-03-30 2012-03-23

Country Status (5)

Country Link
US (1) US20120251588A1 (enExample)
EP (1) EP2510923B1 (enExample)
JP (1) JP5667113B2 (enExample)
CN (1) CN102727458B (enExample)
IN (1) IN2012DE00868A (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5836980B2 (ja) 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
JP6267239B2 (ja) * 2013-03-07 2018-01-24 ダウ グローバル テクノロジーズ エルエルシー 極めて低粘度の新規エステル化セルロースエーテル
US10646573B2 (en) * 2013-06-03 2020-05-12 Shin-Etsu Chemical Co., Ltd. Composition for hot melt extrusion and method for producing hot melt extrudate by using same
JP6203702B2 (ja) * 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
BR112018010354A2 (pt) * 2015-12-08 2018-12-04 Dow Global Technologies Llc composições compreendendo éteres de celulose e éteres de celulose esterificados solúveis em água
US9884922B2 (en) * 2016-03-11 2018-02-06 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate, method for producing the same and composition containing the same
CN106138003A (zh) * 2016-07-11 2016-11-23 成都中牧生物药业有限公司 一种稳定型薄膜包衣预混剂及制备方法
CN105999286A (zh) * 2016-07-11 2016-10-12 成都中牧生物药业有限公司 一种防潮薄膜包衣预混剂及制备方法
CN106075461A (zh) * 2016-07-11 2016-11-09 成都中牧生物药业有限公司 一种遮盖异味的薄膜包衣预混剂及制备方法
JP7050714B2 (ja) * 2019-04-04 2022-04-08 信越化学工業株式会社 腸溶性コーティング用組成物及び固形製剤の製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
JPH08143476A (ja) 1994-11-18 1996-06-04 Japan Tobacco Inc 薬物放出制御膜及び固形製剤
JP2000128779A (ja) 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
AU2003284942A1 (en) 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
DE60309565T3 (de) * 2003-05-02 2015-01-15 Dexcel Ltd. Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
US7294347B2 (en) * 2004-06-21 2007-11-13 Council Of Scientific And Industrial Research Coating compositions for bitterness inhibition
GB0517205D0 (en) * 2005-08-22 2005-09-28 Novartis Ag Organic compounds
KR100888131B1 (ko) 2006-10-10 2009-03-11 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
JP2009191034A (ja) 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
EP2281557A4 (en) * 2008-04-29 2011-08-31 Hanall Biopharma Co Ltd PHARMACEUTICAL FORMULATION CONTAINING AN ANGIOTENSIN II RECEPTOR BLOCKING AGENT

Also Published As

Publication number Publication date
JP2012214461A (ja) 2012-11-08
CN102727458A (zh) 2012-10-17
CN102727458B (zh) 2015-01-14
EP2510923A1 (en) 2012-10-17
US20120251588A1 (en) 2012-10-04
JP5667113B2 (ja) 2015-02-12
EP2510923B1 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
IN2012DE00868A (enExample)
CO6300931A2 (es) Composiciones farmaceuticas que comprenden particulas de liberacion controlada con un nucleo que comprende farmacos levemente basicos
IL220679A (en) Method of manufacture of solid preparations containing basic active pharmaceutical ingredients and the solid preparations produced by the method
ZA201400386B (en) Process for the preparation of a pharmaceutical composition containing pirfenidone in sustained-release tablet form and its application in the regression of human chronic renal failure, breast capsular contracture and hepatic fibrosis
WO2014170755A3 (en) Sustained-release formulations of colchicine and methods of using same
MX2008011579A (es) Forma galenica divisible que permite una liberacion modificada del principio activo.
MX355086B (es) Preparacion de liberacion sostenida de invabradina o sales farmaceuticamente aceptables de la misma.
CO6300903A2 (es) Preparacion de formas farmaceuticas relajantes de musculos esqueleticos de liberacion controlada
IN2014DE00037A (enExample)
AP2014007598A0 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
PH12020550806A1 (en) Core tablet composite preparation comprising mosapride and rabeprazole
BR112015010271A8 (pt) produto de comicronização, processo para o preparo de um produto de comicronização, composição farmacêutica e seus usos
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
NZ603199A (en) Orally disintegrating tablet containing acarbose
NZ627468A (en) Hydrocortisone controlled release formulation
WO2013017910A8 (en) Extended release pharmaceutical compositions containing paliperidone
WO2012014052A3 (en) Novel coated extended release pharmaceutical compositions containing paliperidone
JP2013249283A5 (enExample)
UA105285C2 (uk) Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання
EP2452678A3 (en) Pulsatile-release pharmaceutical formulation of dexlansoprazole
HUP1000565A2 (en) Process for the preparation of pharmaceutically active compound and intermediers
WO2012013994A3 (en) Ph-dependent gradual release pharmaceutical composition
WO2011063774A3 (en) Pectin complexes of steroids and pharmaceutical compositions based thereon